Found: 34
Select item for more details and to access through your institution.
LRRK2 G2019S kinase activity triggers neurotoxic NSF aggregation.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Clinical and pathological features of frontotemporal lobar degeneration with FUS-positive inclusions
- Published in:
- 2010
- By:
- Publication type:
- Abstract
P1-386: Analysis of the involvement of DJ-1 (Park-7) in AD, Pick’s and PSP
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P1-386: Analysis of the involvement of DJ-1 (Park-7) in AD, Pick’s and PSP
- Published in:
- 2006
- By:
- Publication type:
- Abstract
Abnormal glycine metabolism in motor neurone disease: studies on plasma and cerebrospinal fluid.
- Published in:
- Journal of the Royal Society of Medicine, 1993, v. 86, n. 9, p. 501
- By:
- Publication type:
- Article
Neuropathological features of genetically confirmed DYT1 dystonia: investigating disease-specific inclusions.
- Published in:
- Acta Neuropathologica Communications, 2014, v. 2, n. 1, p. 1, doi. 10.1186/s40478-014-0159-x
- By:
- Publication type:
- Article
mTOR independent regulation of macroautophagy by Leucine Rich Repeat Kinase 2 via Beclin-1.
- Published in:
- Scientific Reports, 2016, p. 35106, doi. 10.1038/srep35106
- By:
- Publication type:
- Article
Phosphorylation of 4E-BP1 in the Mammalian Brain Is Not Altered by LRRK2 Expression or Pathogenic Mutations.
- Published in:
- PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0047784
- By:
- Publication type:
- Article
Pathogenic LRRK2 Mutations Do Not Alter Gene Expression in Cell Model Systems or Human Brain Tissue.
- Published in:
- PLoS ONE, 2011, v. 6, n. 7, p. 1, doi. 10.1371/journal.pone.0022489
- By:
- Publication type:
- Article
A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies.
- Published in:
- Brain: A Journal of Neurology, 2011, v. 134, n. 9, p. 2548, doi. 10.1093/brain/awr160
- By:
- Publication type:
- Article
Cellular processes associated with LRRK2 function and dysfunction.
- Published in:
- FEBS Journal, 2015, v. 282, n. 15, p. 2806, doi. 10.1111/febs.13305
- By:
- Publication type:
- Article
GTP binding controls complex formation by the human ROCO protein MASL1.
- Published in:
- FEBS Journal, 2014, v. 281, n. 1, p. 261, doi. 10.1111/febs.12593
- By:
- Publication type:
- Article
Correction: Mutations in LRRK2 linked to Parkinson disease sequester Rab8a to damaged lysosomes and regulate transferrin-mediated iron uptake in microglia.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Mutations in LRRK2 linked to Parkinson disease sequester Rab8a to damaged lysosomes and regulate transferrin-mediated iron uptake in microglia.
- Published in:
- PLoS Biology, 2021, v. 19, n. 12, p. 1, doi. 10.1371/journal.pbio.3001480
- By:
- Publication type:
- Article
TDP-43 in ubiquitinated inclusions in the inferior olives in frontotemporal lobar degeneration and in other neurodegenerative diseases: a degenerative process distinct from normal ageing.
- Published in:
- Acta Neuropathologica, 2009, v. 118, n. 3, p. 359, doi. 10.1007/s00401-009-0526-z
- By:
- Publication type:
- Article
DOPAL initiates αSynuclein-dependent impaired proteostasis and degeneration of neuronal projections in Parkinson's disease.
- Published in:
- NPJ Parkinson's Disease, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41531-023-00485-1
- By:
- Publication type:
- Article
Leucine-rich repeat kinase 2 interacts with p21-activated kinase 6 to control neurite complexity in mammalian brain.
- Published in:
- Journal of Neurochemistry, 2015, v. 135, n. 6, p. 1242, doi. 10.1111/jnc.13369
- By:
- Publication type:
- Article
Physiological and pathological roles of LRRK2 in the nuclear envelope integrity.
- Published in:
- Human Molecular Genetics, 2019, v. 28, n. 23, p. 3982, doi. 10.1093/hmg/ddz245
- By:
- Publication type:
- Article
A Parkinson's disease gene regulatory network identifies the signaling protein RGS2 as a modulator of LRRK2 activity and neuronal toxicity.
- Published in:
- Human Molecular Genetics, 2014, v. 23, n. 18, p. 4887, doi. 10.1093/hmg/ddu202
- By:
- Publication type:
- Article
Parkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegeneration.
- Published in:
- Human Molecular Genetics, 2014, v. 23, n. 17, p. 4621, doi. 10.1093/hmg/ddu178
- By:
- Publication type:
- Article
Functional interaction of Parkinson's disease-associated LRRK2 with members of the dynamin GTPase superfamily.
- Published in:
- Human Molecular Genetics, 2014, v. 23, n. 8, p. 2055, doi. 10.1093/hmg/ddt600
- By:
- Publication type:
- Article
AF-6 is a positive modulator of the PINK1/parkin pathway and is deficient in Parkinson's disease.
- Published in:
- Human Molecular Genetics, 2013, v. 22, n. 10, p. 2083, doi. 10.1093/hmg/ddt058
- By:
- Publication type:
- Article
Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson's disease.
- Published in:
- Acta Neuropathologica, 2022, v. 144, n. 1, p. 81, doi. 10.1007/s00401-022-02437-0
- By:
- Publication type:
- Article
Globular glial tauopathies (GGT) presenting with motor neuron disease or frontotemporal dementia: an emerging group of 4-repeat tauopathies.
- Published in:
- Acta Neuropathologica, 2011, v. 122, n. 4, p. 415, doi. 10.1007/s00401-011-0857-4
- By:
- Publication type:
- Article
Transportin1: a marker of FTLD-FUS.
- Published in:
- Acta Neuropathologica, 2011, v. 122, n. 5, p. 591, doi. 10.1007/s00401-011-0863-6
- By:
- Publication type:
- Article
Differential LRRK2 Signalling and Gene Expression in WT-LRRK2 and G2019S-LRRK2 Mouse Microglia Treated with Zymosan and MLi2.
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 1, p. 53, doi. 10.3390/cells13010053
- By:
- Publication type:
- Article
Advances in the Understanding of Frontotemporal Dementia.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 5, p. 781, doi. 10.3390/cells12050781
- By:
- Publication type:
- Article
Pathological Relevance of Post-Translationally Modified Alpha-Synuclein (pSer87, pSer129, nTyr39) in Idiopathic Parkinson's Disease and Multiple System Atrophy.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 5, p. 906, doi. 10.3390/cells11050906
- By:
- Publication type:
- Article
Perspective: Treatment for Disease Modification in Chronic Neurodegeneration.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 4, p. 873, doi. 10.3390/cells10040873
- By:
- Publication type:
- Article
Vesicular Dysfunction and the Pathogenesis of Parkinson's Disease: Clues From Genetic Studies.
- Published in:
- Frontiers in Neuroscience, 2020, v. 13, p. 1, doi. 10.3389/fnins.2019.01381
- By:
- Publication type:
- Article
Improving the Gene Ontology Resource to Facilitate More Informative Analysis and Interpretation of Alzheimer's Disease Data.
- Published in:
- Genes, 2018, v. 9, n. 12, p. 593, doi. 10.3390/genes9120593
- By:
- Publication type:
- Article
LRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodies.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Brain stem pathology in Parkinson's disease: An evaluation of the Braak staging model.
- Published in:
- Movement Disorders, 2010, v. 25, n. 15, p. 2508, doi. 10.1002/mds.23305
- By:
- Publication type:
- Article
SIAH proteins regulate the degradation and intra‐mitochondrial aggregation of PINK1: Implications for mitochondrial pathology in Parkinson's disease.
- Published in:
- Aging Cell, 2022, v. 21, n. 12, p. 1, doi. 10.1111/acel.13731
- By:
- Publication type:
- Article